Formulations of hepalatide
US10603352B2 · kind B2 · utility
0Cited by
2References
18Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 24, 2014 |
| Grant date | Mar 31, 2020 |
| Priority date | — |
| Expiry date | Jun 24, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2730/10132
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure provides a drug formulation for hepalatide, comprising hepalatide and a buffer salt, and containing or not containing an osmotic regulator and/or an excipient.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.